TileDB

📣 Introducing our latest landmark release: TileDB Carrara Designed for discovering breakthroughs from data – no matter how big, diverse or complex – Carrara defines what a database for discovery should look like. Now teams can do all the work of discovery, with all the data required to do it – both frontier and conventional – all in one place. Join the waitlist: https://tiledb.com/

Are your competitors discovering insights you're missing while your multimodal data sits in siloes? Organizations possess untapped competitive advantage through multimodal data - information spanning text, images, time-series, and specialized scientific formats. Breakthrough discoveries emerge from integrating diverse data types rather than analyzing them separately. While technical and organizational challenges are formidable, the cost of inaction is clear: ceded competitive advantage to organizations that successfully embrace multimodal data strategies. Our CEO breaks it down in his latest blog - link in comments.

Traditional tabular databases can't process the complex multimodal data where tomorrow's medical breakthroughs are hidden. This "frontier data" from genomics, single-cell transcriptomics, spatial and other multimodal data holds the key to revolutionary treatments for cancer and genetic diseases. Multidimensional arrays, the driving force behind our foundational belief that no data is unstructured, provide life science orgs with the structure and scale needed to navigate this new territory effectively. Read more 👇 https://hubs.la/Q03nC5kK0

This Thursday, we're joining AWS for Healthcare & Life Sciences at AWS Genomics Community Day 2025 in San Diego. Jeremy Leipzig, our Product Manager for Population Genomics, will present how TileDB's federated query technology enables researchers to compare genetic information across institutions without transferring sensitive patient data, accelerating rare disease detection while maintaining privacy compliance. #Genomics enthusiasts, grab your seat 👇 https://lnkd.in/e66G2JVg

We're excited to join Ilya Captain, PhD and the next DataDrivenPharma Forum in Berkeley, CA this Wednesday! Devika Garg, PhD, our Director of Product Marketing, will be there to connect with fellow bioinformatics leaders and share how industry-leading biopharma organizations accelerate scientific breakthroughs from #multimodal data using TileDB. RSVP https://lu.ma/jbx03o2x

Traditional databases are failing life sciences teams just when multimodal data holds the key to breakthrough treatments and target discovery. Why? Because tabular databases were designed for entirely different purposes. Our blog post explores what a database designed for discovery really means in today's precision medicine landscape—and why it's more critical than ever for accelerating the path from complex data to life-saving innovations. Read more 👇 https://hubs.ly/Q03lCszS0

It was great to speak on a panel exploring Machine Learning on Multimodal Data: Opportunities & Challenges in Drug Discovery . Cellarity is redefining how medicines are created—starting not with a single target, but with the cellular dysfunction that drives disease. Our platform brings together data, AI, and deep biological insights to develop medicines beyond the reach of traditional approaches. Here are a few takeaways from the conversation: 🔹 Multimodal isn’t a buzzword — it’s the backbone of understanding complex disease biology. 🔹 Benchmarks and biological context must go hand in hand to ensure models are both powerful and meaningful. 🔹 You can't ship science without scalable infrastructure. FAIR data principles enable—not hinder—innovation. 🔹 Data alone isn’t enough. It’s the interpretability and actionability that drive value. Inspired by the thoughtful dialogue with leaders advancing innovation at the intersection of science and AI.

🎉 We kicked off the #AWS Life Sciences Symposium with a bang! A big thank you to everyone who joined us for 🧬 Sips & Sequences yesterday. Special appreciation goes to our partner AWS for Healthcare & Life Sciences and to our exceptional panelists Ariella Sasson, Parul Bordia Doshi, and Mickey Atwal, as well as our moderator Devika Garg, PhD for leading an insightful discussion on the impact of multimodal data and machine learning on science and drug discovery.

⌛ Only few hours left for 🧬 Sips & Sequences. For those finalizing plans, we're still accepting RSVPs. https://lnkd.in/epxNYreg